Association between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID‐19: an observational multicenter study

N Hoertel, M Sánchez‐Rico, E Gulbins… - Clinical …, 2021 - Wiley Online Library
Several medications commonly used for a number of medical conditions share a property of
functional inhibition of acid sphingomyelinase (ASM), or FIASMA. Preclinical and clinical …

Medications modulating the acid sphingomyelinase/ceramide system and 28-day mortality among patients with SARS-CoV-2: an observational study

N Hoertel, K Rezaei, M Sánchez-Rico… - Pharmaceuticals, 2023 - mdpi.com
Prior evidence indicates the potential central role of the acid sphingomyelinase
(ASM)/ceramide system in the infection of cells with SARS-CoV-2. We conducted a …

Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID …

N Hoertel, M Sánchez-Rico, E Gulbins… - Translational …, 2022 - nature.com
The acid sphingomyelinase (ASM)/ceramide system may provide a useful framework for
better understanding SARS-CoV-2 infection and the repurposing of psychotropic …

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms

N Hoertel, M Sánchez-Rico, C Cougoule… - Molecular …, 2021 - nature.com
We read with great interest the correspondence letters of Salles et al.[1] and Stip et al.[2],
following our multicenter observational retrospective study that showed a substantial …

Association between functional inhibitors of acid sphingomyelinase (FIASMAs) and reduced risk of death in COVID-19 patients: a retrospective cohort study

G Darquennes, P Le Corre, O Le Moine, G Loas - Pharmaceuticals, 2021 - mdpi.com
Given the current scarcity of curative treatment of COVID-19, the search for an effective
treatment modality among all available medications has become a priority. This study aimed …

Antidepressant use and its association with 28-day mortality in inpatients with SARS-CoV-2: support for the FIASMA model against COVID-19

N Hoertel, M Sánchez-Rico, J Kornhuber… - Journal of Clinical …, 2022 - mdpi.com
To reduce Coronavirus Disease 2019 (COVID-19)-related mortality and morbidity, widely
available oral COVID-19 treatments are urgently needed. Certain antidepressants, such as …

Do the selective serotonin reuptake inhibitor antidepressants fluoxetine and fluvoxamine reduce mortality among patients with COVID-19?

N Hoertel - JAMA network open, 2021 - jamanetwork.com
In a large, multicenter, retrospective cohort study of 83 584 patients with laboratory-
confirmed COVID-19 who had an emergency department or urgent care visit or were …

The acid sphingomyelinase/ceramide system in COVID-19

J Kornhuber, N Hoertel, E Gulbins - Molecular Psychiatry, 2022 - nature.com
Acid sphingomyelinase (ASM) cleaves sphingomyelin into the highly lipophilic ceramide,
which forms large gel-like rafts/platforms in the plasma membrane. We showed that SARS …

Activation of sphingomyelinase-ceramide-pathway in COVID-19 purposes its inhibition for therapeutic strategies

M Abusukhun, MS Winkler, S Pöhlmann… - Frontiers in …, 2021 - frontiersin.org
Effective treatment strategies for severe coronavirus disease (COVID-19) remain scarce.
Hydrolysis of membrane-embedded, inert sphingomyelin by stress responsive …

Pharmacological inhibition of acid sphingomyelinase prevents uptake of SARS-CoV-2 by epithelial cells

A Carpinteiro, MJ Edwards, M Hoffmann, G Kochs… - Cell Reports …, 2020 - cell.com
The acid sphingomyelinase/ceramide system plays an important role in bacterial and viral
infections. Here, we report that either pharmacological inhibition of acid sphingomyelinase …